View in EDS HTML Full Text PDF Full Text

NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma.

Saved in:
Bibliographic Details
Title: NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma.
Authors: Schmidt, Moritz1,2 (AUTHOR), Mattern, Sven3 (AUTHOR), Singer, Stephan3 (AUTHOR), Schulze, Martin4 (AUTHOR), Biskup, Saskia4,5 (AUTHOR), Krumm, Patrick6 (AUTHOR), Lauer, Ulrich M.1,2,7 (AUTHOR), Zender, Lars1,2,7 (AUTHOR), Hinterleitner, Clemens1,2,8 (AUTHOR), Hinterleitner, Martina1,2 (AUTHOR) martina.hinterleitner@med.uni-tuebingen.de
Source: Journal of Cancer Research & Clinical Oncology. Aug2023, Vol. 149 Issue 9, p6753-6757. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01715216
DOI:10.1007/s00432-023-04598-1